China NMPA Product Recall - Peripheral self-expanding Nitinol stent system

BIOTRONIK AG, the manufacturer, has initiated a voluntary Class III recall for its self-expanding nitinol stent system, registered under National Medical Device Registration Certificate No. 20153131894. This action was reported by BIOTRONIK (Beijing) Medical Devices Co., Ltd. to the National Medical Products Administration (NMPA) on February 25, 2025. The primary issue identified is a discrepancy between the actual dimensions of the medical devices and the information printed on their packaging. Such inaccuracies are critical as they could potentially lead to inappropriate product selection or use, posing risks to patient safety. The NMPA is overseeing this regulatory action, which requires BIOTRONIK AG to manage the recall process according to established guidelines. A Class III recall generally signifies that the use of, or exposure to, the affected product is unlikely to cause adverse health consequences. It is noteworthy that the specific models and batches involved in this recall were not imported into the Chinese market. This event highlights the stringent quality control standards expected within the medical device industry and the continuous regulatory oversight by the NMPA to ensure public health and safety.